Integra LifeSciences had the kind of quarter that makes a finance chief smile and a sales leader reach for another cup of coffee. Its third-quarter 2026 report paired sharply stronger cash generation with modest revenue growth and a manufacturing recovery complicated by the July flooding in Cincinnati.
Company News Premium
Integra Cash Flow Surges as Sales Make a Slow Recovery
1 min read Premium comments

Integra LifeSciences#neurosurgery3Q26 earnings report
Author
React:
